EIP
DGX icon

Ellis Investment Partners’s Quest Diagnostics DGX Stock Holding History

Ellis Investment Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-86
Closed -$11K – 783
2021
Q2 		$11K Hold
86
– – ﹤0.01% 591
2021
Q1 		$11K Hold
86
– – ﹤0.01% 566
2020
Q4 		$10K Buy
86
+1
+1% +$122 ﹤0.01% 569
2020
Q3 		$9K Hold
85
– – ﹤0.01% 568
2020
Q2 		$9K Buy
+85
New +$9.02K ﹤0.01% 551

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ellis Investment Partners's DGX Position: Q3 2021 in Review

Ellis Investment Partners sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 86 shares — an estimated $11K sold.

Ellis Investment Partners first reported a position in DGX in Q2 2020 and held it in 5 quarters. The position peaked at $11K in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Ellis Investment Partners reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Ellis Investment Partners sold 86 Quest Diagnostics shares in Q3 2021, an estimated $11K.
  • Ellis Investment Partners first reported a position in Quest Diagnostics in Q2 2020 and held it in 5 quarters.
  • Ellis Investment Partners's Quest Diagnostics position peaked at $11K in Q2 2021.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Ellis Investment Partners's 13F filing for Q3 2021, filed 21 Oct 2021.